SEC Filings
Filing date | Form | Description | View |
---|---|---|---|
4 | Statement of changes in beneficial ownership of securities |
View HTML | |
8-K | Report of unscheduled material events or corporate event |
View HTML | |
S-8 | Securities offered to employees pursuant to employee benefit plans |
View HTML | |
DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") |
View HTML | |
10-K | Annual report which provides a comprehensive overview of the company for the past year |
View HTML EX-101.INS - EX-101.INS | |
8-K | Report of unscheduled material events or corporate event |
View HTML | |
8-K | Report of unscheduled material events or corporate event |
View HTML | |
4 | Statement of changes in beneficial ownership of securities |
View HTML | |
4 | Statement of changes in beneficial ownership of securities |
View HTML | |
4 | Statement of changes in beneficial ownership of securities |
View HTML |
Data provided by Kaleidoscope.
For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.